D. E. Shaw & Co., Inc. Tenaya Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 126,497 shares of TNYA stock, worth $301,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,497
Holding current value
$301,062
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.93 - $3.99 $244,139 - $504,723
126,497 New
126,497 $244,000
Q4 2023

Feb 14, 2024
SELL
$1.73 - $3.39 $50,296 - $98,557
-29,073 Reduced 23.33%
95,567 $309,000
Q3 2023

Nov 14, 2023
BUY
$2.55 - $5.65 $95,186 - $210,903
37,328 Added 42.75%
124,640 $317,000
Q2 2023

Aug 14, 2023
BUY
$2.64 - $7.64 $199,261 - $576,651
75,478 Added 637.81%
87,312 $512,000
Q1 2023

May 15, 2023
SELL
$1.92 - $3.59 $49,923 - $93,347
-26,002 Reduced 68.72%
11,834 $33,000
Q4 2022

Feb 14, 2023
BUY
$1.68 - $3.19 $16,047 - $30,470
9,552 Added 33.77%
37,836 $76,000
Q3 2022

Nov 14, 2022
BUY
$2.9 - $5.88 $8,247 - $16,722
2,844 Added 11.18%
28,284 $82,000
Q2 2022

Aug 15, 2022
SELL
$5.01 - $14.12 $65,510 - $184,633
-13,076 Reduced 33.95%
25,440 $143,000
Q1 2022

May 16, 2022
BUY
$9.41 - $19.3 $362,435 - $743,358
38,516 New
38,516 $454,000

Others Institutions Holding TNYA

# of Institutions
96
Shares Held
56.3M
Call Options Held
900
Put Options Held
400
View Full List

About Tenaya Therapeutics, Inc.

TNYA Quotes by TradingView
  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $98.4M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email